Head-To-Head Analysis: Monogram Orthopaedics (NASDAQ:MGRM) vs. Inspira Technologies Oxy B.H.N. (NASDAQ:IINN)

Monogram Orthopaedics (NASDAQ:MGRM) and Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, valuation, dividends, profitability, risk and analyst recommendations.

Valuation and Earnings

This table compares Monogram Orthopaedics and Inspira Technologies Oxy B.H.N.”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Monogram Orthopaedics	$370,000.00	264.28	-$13.74 million	($0.47)	-6.06
Inspira Technologies Oxy B.H.N.	N/A	N/A	-$11.29 million	N/A	N/A

Inspira Technologies Oxy B.H.N. has lower revenue, but higher earnings than Monogram Orthopaedics.

Institutional & Insider Ownership

0.5% of Monogram Orthopaedics shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies Oxy B.H.N. shares are owned by institutional investors. 28.1% of Monogram Orthopaedics shares are owned by company insiders. Comparatively, 29.4% of Inspira Technologies Oxy B.H.N. shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Monogram Orthopaedics and Inspira Technologies Oxy B.H.N.’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Monogram Orthopaedics	N/A	-130.90%	-106.38%
Inspira Technologies Oxy B.H.N.	N/A	N/A	N/A

Volatility and Risk

Monogram Orthopaedics has a beta of 1.51, indicating that its share price is 51% more volatile than the S&P 500. Comparatively, Inspira Technologies Oxy B.H.N. has a beta of 2.13, indicating that its share price is 113% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and price targets for Monogram Orthopaedics and Inspira Technologies Oxy B.H.N., as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Monogram Orthopaedics	0	0	1	1	3.50
Inspira Technologies Oxy B.H.N.	0	0	0	0	0.00

Monogram Orthopaedics currently has a consensus target price of $4.00, suggesting a potential upside of 40.35%. Given Monogram Orthopaedics’ stronger consensus rating and higher possible upside, equities analysts clearly believe Monogram Orthopaedics is more favorable than Inspira Technologies Oxy B.H.N..

Summary

Inspira Technologies Oxy B.H.N. beats Monogram Orthopaedics on 6 of the 11 factors compared between the two stocks.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.

About Inspira Technologies Oxy B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.